Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Designating an Orphan Product: Drugs and Biological Products

Designating an Orphan Product: Drugs and Biological Products

                        Orphan Drug Designation Request Form
          Orphan Drug Act - Relevant Excerpts
          Frequently Asked Questions (FAQ) About Designating an Orphan Product
          Orphan Drug Designation: Disease Considerations
          Clinical Superiority Findings
          Instructions for Searchable Designation Database
          Public Identification of Orphan Drug Designation
          Improving the Prevention, Diagnosis, and Treatment of Rare and Neglected Diseases; FDA Report to Congress
          Contact Us Home
          For Industry
          Medical products for rare diseases and conditions
          Designating an Orphan Product: Drugs and Biological Products
          Public Identification of Orphan Drug DesignationDesignating an Orphan Product: Drugs and Biological Products Public Identification of Orphan Drug Designation
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Notice to Certain Orphan-Drug Designation Holders:**

The Food and Drug Administration (FDA) publishes the generic name and/or trade name of a drug on our website at Search Orphan Drug Designations and Approvals after we designate a drug as an orphan drug.It has come to our attention that a small subset of drugs that have received orphan designation were published on our public database using a non-informative code. After careful consideration of this matter, we have concluded that the Orphan Drug Act mandates that the FDA identify to the public products that have received orphan-drug designation. We typically provide this required notice by publishing a generic or trade name of an orphan-designated drug. If, as is the case for some products, there is no generic or trade name, publishing a non-informative code does not meet the statutory disclosure requirement because the public would not be able to identify the drug that has received orphan designation. Therefore, for the small subset of drugs that were published on our public database using a non-informative code, we have replaced each such code with an informative identifier.

Despite reasonable efforts, we were unable to notify a small proportion of affected sponsors. It appears that some sponsors may have gone out of business or may have transferred ownership of or beneficial interest in orphan-drug designation without informing FDA.(We remind sponsors of their obligations to notify us of any change in ownership of orphan-drug designation, under 21 CFR 316.27, and to submit brief progress reports to us on an annual basis, under 21 CFR 316.30.)

Through this notice, FDA seeks to inform sponsors whom we have been otherwise unable to notify that, pursuant to the Orphan Drug Act's disclosure requirements, all non-informative codes in our public orphan drug designations database have been replaced with corresponding informative identifiers. If you believe this notice applies to you, click here and enter your product. If you believe that your product’s current identifier does not accurately identify your product to the public, please promptly contact the Office of Orphan Products Development - OPDAR: OPDAR@fda.hhs.gov or 301-796-8660.

We appreciate your attention to this matter. If you have any questions, please contact OPDAR using the above contact information.

Thank you,
The Office of Orphan Products Development, FDA

                                                                                  Content current as of:
      03/09/2018
              
              
Regulated Product(s)
		 DrugsDesignating an Orphan Product: Drugs and Biological Products

          
                        Orphan Drug Designation Request Form
          Orphan Drug Act - Relevant Excerpts
          Frequently Asked Questions (FAQ) About Designating an Orphan Product
          Orphan Drug Designation: Disease Considerations
          Clinical Superiority Findings
          Instructions for Searchable Designation Database
          Public Identification of Orphan Drug Designation
          Improving the Prevention, Diagnosis, and Treatment of Rare and Neglected Diseases; FDA Report to Congress
          Contact Us
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop